Early research (Phase 1)Study completedNCT06224543What this trial is testingMR Image Synthesis With Low Gadobutrol Dose and AIWho this might be right forEnhancing Brain Lesions Subtle Medical 60
Not applicableStudy completedNCT00214175What this trial is testingDetermination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance RadiotherapyWho this might be right forGliomaBrain Neoplasms University of Wisconsin, Madison 44
Not applicableStudy completedNCT01312363What this trial is testingStudy for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) PatientsWho this might be right forAlzheimer's Disease Seoul National University Hospital 300
Not applicableStudy completedNCT07128212What this trial is testingAtorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1Who this might be right forIschemic White Matter Lesions (WMIL)Cerebral Small Vessel DiseaseVascular Cell Adhesion Molecule-1+1 more Suzhou Municipal Hospital of Anhui Province 401
Not applicableStudy completedNCT02480452What this trial is testingBrain Lesions in Relation to Motor Profiles of Children With Cerebral Visual Impairment.Who this might be right forVisual Pathway Diseases; Neuroimaging Universitaire Ziekenhuizen KU Leuven 600
Not applicableEnded earlyNCT02184130What this trial is testingAltered Vestibular Perception and Transcranial Magnetic StimulationWho this might be right forVerticality PerceptionSelf-motion Perception University of Zurich 7
Not applicableStudy completedNCT02506244What this trial is testingMHealth Screening to Prevent StrokesWho this might be right forAtrial Fibrillation Scripps Translational Science Institute 6,135
Not applicableStudy completedNCT02250755What this trial is testingMRI Perfusion on T1 and T2 Brain Lesion(s)Who this might be right forLung Carcinoma Metastatic to the Brain University Hospital, Lille 30
Early research (Phase 1)Study completedNCT02728947What this trial is testingPharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's DiseaseWho this might be right forParkinson's Disease Luye Pharma Group Ltd. 28
Not applicableStudy completedNCT01520532What this trial is testingEvaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC)Who this might be right forAtrial Fibrillation Medtronic Cardiac Rhythm and Heart Failure 60
Testing effectiveness (Phase 2)Study completedNCT00879658What this trial is testingSafety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple SclerosisWho this might be right forRelapsing-remitting Multiple Sclerosis Novartis Pharmaceuticals 297
Testing effectiveness (Phase 2)Study completedNCT00013585What this trial is testingSafety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV PatientsWho this might be right forCognition DisordersHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 127
Testing effectiveness (Phase 2)Study completedNCT00676715What this trial is testingThe Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-Remitting Genentech, Inc. 220
Not applicableStudy completedNCT06848712What this trial is testingBrain Structural Abnormalities in Patients With VertigoWho this might be right forVertigoMRI University of Pecs 464
Testing effectiveness (Phase 2)Study completedNCT01024907What this trial is testingProton Beam Radiation Therapy in Treating Patients With Low Grade GliomasWho this might be right forAdult Brain TumorAdult Brain Stem GliomaAdult Diffuse Astrocytoma+9 more Abramson Cancer Center at Penn Medicine 23
Not applicableStudy completedNCT04178395What this trial is testingEarly Neurophysiological Interventions in Acute Cerebral LesionsWho this might be right forStrokeAcute Stroke Sara Yagüe MD 20
Testing effectiveness (Phase 2)Study completedNCT02720445What this trial is testingMemory Improvement Through Nicotine Dosing (MIND) StudyWho this might be right forMild Cognitive Impairment University of Southern California 348
Testing effectiveness (Phase 2)Looking for participantsNCT05359653What this trial is testingAssessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyWho this might be right forMultiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more University of California, San Francisco 74
Testing effectiveness (Phase 2)Study completedNCT01418820What this trial is testingParaorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic LesionsWho this might be right forComplete HemianopiaIncomplete HemianopiaScotoma+4 more University of Magdeburg 32
Large-scale testing (Phase 3)Study completedNCT00799890What this trial is testingSunphenon in Progressive Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis Friedemann Paul 61